We're going Behind the Mystery of two rare diseases: Castleman disease and chondrosarcoma. There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades. Inhibrx, a clinical-stage biotechnology company, is dedicated to helping people with life-threatening conditions. They are developing a therapeutic option for chondrosarcoma called INBRX-109, which is currently in clinical trials . Then, meet with physician, scientist, patient, and best-selling author of Chasing My Cure David Fajgenbaum to learn more about Castleman Disease . Plus, one patient's journey from facing his own mortality to finding hope through advocacy.
